Literature DB >> 8008153

Mixed oligoastrocytomas: a survival and prognostic factor analysis.

E G Shaw1, B W Scheithauer, J R O'Fallon, D H Davis.   

Abstract

Seventy-one patients with supratentorial mixed oligoastrocytomas underwent surgery only (5 patients) or surgery with postoperative radiation therapy (66 patients) between 1960 and 1982. The median survival for these 71 patients was 5.8 years and the 5-, 10-, and 15-year survival rates were 55, 29, and 17%, respectively--values significantly different from those of an age- and sex-matched normal reference population. Uni- and multivariate survival analyses were applied to 14 possible prognostic factors, including the following: patient factors--age, sex, and seizures; tumor factors--site, size, side, computed tomographic enhancement, and calcification; pathological factors--tumor grade and dominant cellular component; and treatment factors--extent of surgical resection, lobectomy, and radiation dose and field. Of these factors, tumor grade, as determined by the Kernohan method, was the most strongly associated with survival. The 60 patients with Grades 1 and 2 tumors had a median survival of approximately 6.3 years and 5- and 10-year survival rates of 58% and 32%, respectively, compared with 2.8 years (36 and 9%, respectively) for the 11 patients with Grades 3 and 4 tumors. Age < 37 years, gross total resection, partial brain radiation, and radiation dose > or = 5000 cGy were other factors significantly associated with improved survival in both uni- and multivariate models. Three of five patients not receiving postoperative radiation therapy experienced tumor recurrence and died. Seven of eight patients from whom tissue was obtained at the time of tumor progression demonstrated anaplastic transformation.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1994        PMID: 8008153     DOI: 10.1227/00006123-199404000-00002

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  21 in total

1.  Diagnosis of malignant glioma: role of neuropathology.

Authors:  Daniel J Brat; Richard A Prayson; Timothy C Ryken; Jeffrey J Olson
Journal:  J Neurooncol       Date:  2008-08-20       Impact factor: 4.130

2.  Supratentorial gliomas: a comparative study by grade and histologic type.

Authors:  E G Shaw; B W Scheithauer; J R O'Fallon
Journal:  J Neurooncol       Date:  1997-02       Impact factor: 4.130

Review 3.  Low grade gliomas: functional mapping resection strategies, extent of resection, and outcome.

Authors:  M S Berger; R C Rostomily
Journal:  J Neurooncol       Date:  1997-08       Impact factor: 4.130

4.  Oligoastrocytomas: a clinicopathological study of 52 cases.

Authors:  H G Krouwer; S G van Duinen; W Kamphorst; P van der Valk; A Algra
Journal:  J Neurooncol       Date:  1997-07       Impact factor: 4.130

5.  Advantage of treating anaplastic gliomas with aggressive protocol combining chemotherapy and radiotherapy.

Authors:  A Boiardi; A Silvani; A Pozzi; M Farinotti; L Fariselli; G Broggi; A Salmaggi
Journal:  J Neurooncol       Date:  1997-09       Impact factor: 4.130

6.  Comparative genetic analysis of metachronous anaplastic oligoastrocytomas with extended recurrence-free interval.

Authors:  Ramon Martinez; Hans-Konrad Schackert; Matthias Kirsch; Werner Paulus; Stefan Joos; Gabriele Schackert
Journal:  J Neurooncol       Date:  2005-04       Impact factor: 4.130

Review 7.  New therapies of primary CNS lymphomas and oligodendrogliomas.

Authors:  D R Macdonald
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

8.  Histological and MR correlations in Gliomatosis cerebri.

Authors:  Paule Peretti-Viton; Hervé Brunel; Olivier Chinot; Clément Daniel; Maryline Barrié; Corinne Bouvier; Dominique Figarella-Branger; Stéphane Fuentes; Henry Dufour; François Grisoli
Journal:  J Neurooncol       Date:  2002-09       Impact factor: 4.130

9.  Serum GFAP autoantibody as an ELISA-detectable glioma marker.

Authors:  Ping Wei; Wei Zhang; Liu-Song Yang; Hai-Shi Zhang; Xiao-En Xu; Ying-Hua Jiang; Feng-Ping Huang; Qian Shi
Journal:  Tumour Biol       Date:  2013-04-16

Review 10.  Low-grade gliomas.

Authors:  Jimmy Ruiz; Glenn J Lesser
Journal:  Curr Treat Options Oncol       Date:  2009-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.